News

The $1,000 genome has arrived, providing the spur for personalised healthcare to move from theory to practice. Some existing examples of best practice and roadmaps for the future are pointing the way

Personalised healthcare promises long-term value. But how can Europe justify the upfront costs at a time of massive cuts in public spending?

Demand for fuel and power is set to keep rising strongly over the next two decades, led by the fast growing economies of China and India, projects BP

Awards programme, Feb. 21 in Brussels, is part of a Commission drive to stimulate more – and better - entrepreneurship in Europe

A new study finds that investment in computer, communications and diagnostics technologies could drastically cut the long-term care costs for breast cancer and cardiovascular disease, through better use of patient screening and adherence to treatment.

Researchers, academic policy experts and commission officials gathered in Brussels on 23 November to explore a systems approach to energy innovation at a Science|Business symposium

They are some of the largest spenders on research. But now, as pharmaceutical companies look to external collaboration and in-licensed products to fuel innovation, the internal R&D operation is having to justify the return on investment for the first time

Research costs are up 47% - and a new EU study analyses why

Cloud computing has become a standard way of working online – and a Science|Business seminar in the European Parliament looked at the impact on small companies

Entrepreneurs from the United Kingdom gained the most nominations at this year’s Academic Enterprise Awards. Three UK spin-outs are among the top 12 chosen to go through to final awards in Brussels on 21 February, 2012.